Anthony Perissinotti, PharmD, BCOP

Closing out his discussion on tumor lysis syndrome, Anthony Perissinotti, PharmD, BCOP, shares practical advice on its identification and management.

Guideline-directed treatment strategies available to patients with identified tumor lysis syndrome.

An overview of the prophylactic strategies that may be utilized to reduce the likelihood of tumor lysis syndrome.

Expert perspective on the role of a pharmacist in managing patients with identified tumor lysis syndrome.

Anthony Perissinotti, PharmD, BCOP, highlights associated risk for tumor lysis syndrome and identifies signs and symptoms.